Adrian Goodey is a Principal Scientist in the Analytical Sciences group within Merck Research Laboratories. In this role, Dr. Goodey has led development teams for a range of drug products including solid-oral, inhalers, nasal sprays and long-acting polymeric implants. Prior to joining the pharmaceutical industry in 2007 with Schering-Plough, Dr. Goodey earned a B.Sc. in chemistry from Emory University, completed a PhD in chemistry from the University of Texas at Austin, and then served as an ACS/PRF Alternative Energy Postdoctoral Fellow at the Pennsylvania State University. Dr. Goodey currently chairs the IPAC-RS Cascade Impaction working group and serves on the McMaster University Aerosol School faculty.